Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

Roughly 8000 Brits died from respiratory syncytial virus infections last year, with tens of thousands likely clogging up ...

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...

The recommendation builds on the committee’s June 2024 vote for the use of RSV vaccines for people aged 60 to 74 at high risk ...

For meningococcal vaccines, ACIP recommended that GSK's pentavalent vaccine (Penmenvy), designed to protect against A, B, C, ...

Ziresovir's Phase III results mark a significant milestone, representing the first clinical validation of an antiviral's ...

Most children begin to feel better within 2 to 3 days of starting treatment. It is important to keep giving your child antibiotics until they are finished, even if they seem to be getting better.

Children staying at St. Jude India ChildCare Centres (St. Judes) who are undergoing cancer treatment in Mumbai and Chennai hospitals, have been recently introduced with a chess program that aims ...

Coinfection with RSV, REV, and MPV was significantly associated with treatment failure and prolonged treatment in children with viral LRTIs on respiratory support.

Injured children from Gaza arrived at O'Hare on Sunday to receive life-saving medical treatment, thanks to HEAL Palestine. The children, who were flown from Egypt, will stay with host families in ...